Showing results (11-20 of 97) with videos related to
Sort By:
Pageof 10
Drugs|January 10, 2019
Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future OptionsNicolas Collongues, Estelle Ayme-Dietrich, Laurent Monassier, et al.BMC Neurology|August 22, 2012
Inflammatory-like presentation of CADASIL: a diagnostic challengeNicolas Collongues, Nathalie Derache, Frédéric Blanc, et al.Journal of Neurology|April 17, 2022
Anti-CD20 immunotherapy in progressive multiple sclerosis: 2-year real-world follow-up of 108 patientsMaximilian Einsiedler, Laurent Kremer, Marie Fleury, et al.Multiple Sclerosis and Related Disorders|February 21, 2014
Review of Animal Models of Neuromyelitis OpticaMelina V Jones, Nicolas Collongues, Jerome de Seze, et al.Expert Review of Neurotherapeutics|May 26, 2018
Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeuticsNicolas Collongues, Christine Patte-Mensah, Jérôme De Seze, et al.Neurology|August 31, 2016
Neuromyelitis optica spectrum disorders in children and adolescentsSilvia Tenembaum, Tanuja Chitnis, Ichiro Nakashima, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2013
Relapsing optic neuritis: a multicentre study of 62 patientsAurélien Benoilid, Caroline Tilikete, Nicolas Collongues, et al.Muscle & Nerve|September 4, 2012
Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter studyNicolas Collongues, Olivier Casez, Arnaud Lacour, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 3, 2010
Magnetic resonance spectroscopy evaluation in patients with neuromyelitis opticaJérôme de Seze, Frédéric Blanc, Stéphane Kremer, et al.BMC Neurology|June 3, 2014
Chronic Bickerstaff's encephalitis with cognitive impairment, a reality?Mathilde Renaud, Jérôme Aupy, Guillaume Camuset, et al.Pageof 10